Patents by Inventor Natalie Ostretova-Golts

Natalie Ostretova-Golts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated peptides to treat alpha-synuclein diseases
    Patent number: 7605133
    Abstract: The present invention relates to drug screening methods and methods of preventing neural tissue damage caused by ?-synuclein aggregation. These methods are especially useful in the design and development of inhibitors of Lewy body diseases and other synucleinopathies, and further useful in the treatment of such neurodegenerative diseases, particularly Parkinson's Disease.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: October 20, 2009
    Assignee: Panacea Pharmaceuticals, Inc.
    Inventors: Benjamin Wolozin, Natalie Ostretova-Golts, Michael S. Lebowitz
  • Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
    Publication number: 20050032131
    Abstract: The present invention relates to drug screening methods and methods of preventing neural tissue damage caused by ?-synuclein aggregation. These methods are especially useful in the design and development of inhibitors of Lewy body diseases and other synucleinopathies, and further useful in the treatment of such neurodegenerative diseases, particularly Parkinson's Disease.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 10, 2005
    Inventors: Benjamin Wolozin, Natalie Ostretova-Golts, Michael Lebowitz
  • Compositions for inhibiting the aggregation pathway of &agr;-synuclein
    Patent number: 6780971
    Abstract: The present invention provides methods of determining aggregation of &agr;-synuclein, which are a hallmark of Lewy body diseases such as Parkinson's disease. Also disclosed are inhibitors of the aggregation, including magnesium and &agr;-synuclein binding peptides. The inhibitors are useful in the treatment of Lewy body diseases.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: August 24, 2004
    Assignee: Panacea Pharmaceuticals, Inc.
    Inventors: Benjamin Wolozin, Natalie Ostretova-Golts, Michael S. Lebowitz
  • Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
    Publication number: 20020151464
    Abstract: The present invention provides methods of determining aggregation of &agr;-synuclein, which are a hallmark of Lewy body diseases such as Parkinson's disease. Also disclosed are inhibitors of the aggregation, including magnesium and &agr;-synuclein binding peptides. The inhibitors are useful in the treatment of Lewy body diseases.
    Type: Application
    Filed: July 9, 2001
    Publication date: October 17, 2002
    Inventors: Benjamin Wolozin, Natalie Ostretova-Golts, Michael S. Lebowitz